Researchers from North Carolina State University and Duke University have developed nanoscale "patches" that can be used to sensitize targeted cell receptors, making them more responsive to signals that control cell activity. The finding holds promise for promoting healing and facilitating tissue engineering research.
When golden staph enters our skin it can identify the key immune cells and 'nuke' our body's immune response.Now we know how, thanks to an international research group led by dermatologists from the Centenary Institute and the University of Sydney.
This important scientific breakthrough, developed by the University of Granada, will aid the immediate use of artificially-grown skin for major burn patients, since the skin could be stored in tissue banks and made available when needed.
Researchers have identified a genomic variant strongly associated with sensitivity to the sun, brown hair, blue eyes - and freckles. In the study of Icelanders the researchers uncovered an intricate pathway involving the interspersed DNA sequence, or non-coding region, of a gene that is among a few dozen that are associated with human pigmentation traits.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
A gut-clinging worm with a proboscis that swells has inspired a new approach to healing and protecting wounds normally treated with sutures, staples and adhesive dressings.Traditional methods for protecting and sealing wounds, such as staples, sutures and adhesive dressings have limitations.
Actelion (SIX: ATLN) has announced that VALCHLOR™ (mechlorethamine), the first and only FDA-approved topical formulation of mechlorethamine, is now available for patients in the United States (US).
The layers of skin that form the first line of defence in the body's fight against infection have revealed a unanticipated secret.The single cell type that was thought to be behind the skin's immune defence has been found to have a doppelganger, with researchers from the Walter and Eliza Hall Institute showing the cells, despite appearing identical, are actually two different types.
Skin provides a first line of defense against viruses, bacteria and parasites that might otherwise make people ill. When an injury breaks that barrier, a systematic chain of molecular signaling launches to close the wound and re-establish the skin's layer of protection.
Researchers who found giving mice baths in diluted bleach blocked inflammatory processes that damage skin suggest if the same works in humans, then it could offer a new way to treat skin inflammation from radiotherapy or excessive sun exposure, or even skin damage caused by aging.